Form 4 Nutanix, Inc. For: Aug 26 Filed by: Sivaraman Rukmini
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Nutanix (NTNX) PT Raised to $75 at RBC Capital
August 29, 2024 7:10 AM EDTRBC Capital analyst Matthew Hedberg raised the price target on Nutanix (NASDAQ: NTNX) to $75.00 (from $70.00) while maintaining a Outperform rating.
The analyst comments "Despite uncertainty about the initial FY/25 guide, Nutanix delivered solid Q4 results with ACV and revenue ahead of... More
Nutanix (NTNX) PT Raised to $77 at Piper Sandler, 'Top Pick'
August 29, 2024 5:50 AM EDTPiper Sandler analyst James Fish raised the price target on Nutanix (NASDAQ: NTNX) to $77.00 (from $76.00) while maintaining a Overweight rating.
The analyst comments "As typical over the last few years, Nutanix's overly cautious FQ3 tone resulted in expectations being reset... More
Nutanix (NTNX) PT Raised to $75 at JPMorgan
August 29, 2024 5:39 AM EDTJPMorgan analyst Mark Murphy raised the price target on Nutanix (NASDAQ: NTNX) to $75.00 (from $65.00) while maintaining a Overweight rating.
The analyst comments "Nutanix reported a solid end to its fiscal year exceeding all key guided metrics, while forward looking metrics continued to exhibit robust growth. The strength in the quarter was evident in the 22% y/y ARR growth and 21% y/y ACV billings growth, with the later landing 13 points above consensus... More

